[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Antihypertensive Drugs Market Report 2016

November 2016 | 120 pages | ID: E240ED53E2DEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Antihypertensive Drugs

Revenue, means the sales value of Antihypertensive Drugs

This report studies sales (consumption) of Antihypertensive Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Novartis AG
  • Pfizer
  • Sanofi S.A
  • Johnson & Johnson
  • Daiichi Sankyo
  • Merck & Co.
  • Ranbaxy Laboratories
  • Lupin
  • AstraZeneca
  • Dr. Reddy's Laboratories
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Antihypertensive Drugs in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Angiotensin Converting Enzyme Inhibitors (ACE)
  • Diuretics
  • Beta Blockers
  • Calcium Channel Blockers
  • Vasodilators
  • Alpha blockers
  • Renin inhibitors
Split by application, this report focuses on sales, market share and growth rate of Antihypertensive Drugs in each application, can be divided into
  • Diagnostic centers
  • Hospitals
  • Home health care
Europe Antihypertensive Drugs Market Report 2016

1 ANTIHYPERTENSIVE DRUGS OVERVIEW

1.1 Product Overview and Scope of Antihypertensive Drugs
1.2 Classification of Antihypertensive Drugs
  1.2.1 Angiotensin Converting Enzyme Inhibitors (ACE)
  1.2.2 Diuretics
  1.2.3 Beta Blockers
  1.2.4 Calcium Channel Blockers
  1.2.5 Vasodilators
  1.2.6 Alpha blockers
  1.2.7 Renin inhibitors
1.3 Application of Antihypertensive Drugs
  1.3.1 Diagnostic centers
  1.3.2 Hospitals
  1.3.3 Home health care
1.4 Antihypertensive Drugs Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Antihypertensive Drugs (2011-2021)
  1.5.1 Europe Antihypertensive Drugs Sales and Growth Rate (2011-2021)
  1.5.2 Europe Antihypertensive Drugs Revenue and Growth Rate (2011-2021)

2 EUROPE ANTIHYPERTENSIVE DRUGS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Antihypertensive Drugs Market Competition by Manufacturers
  2.1.1 Europe Antihypertensive Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Antihypertensive Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Antihypertensive Drugs (Volume and Value) by Type
  2.2.1 Europe Antihypertensive Drugs Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Antihypertensive Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Antihypertensive Drugs (Volume and Value) by Countries
  2.3.1 Europe Antihypertensive Drugs Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Antihypertensive Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Antihypertensive Drugs (Volume) by Application

3 GERMANY ANTIHYPERTENSIVE DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Antihypertensive Drugs Sales and Value (2011-2016)
  3.1.1 Germany Antihypertensive Drugs Sales and Growth Rate (2011-2016)
  3.1.2 Germany Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Antihypertensive Drugs Sales Price Trend (2011-2016)
3.2 Germany Antihypertensive Drugs Sales and Market Share by Manufacturers
3.3 Germany Antihypertensive Drugs Sales and Market Share by Type
3.4 Germany Antihypertensive Drugs Sales and Market Share by Application

4 FRANCE ANTIHYPERTENSIVE DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 France Antihypertensive Drugs Sales and Value (2011-2016)
  4.1.1 France Antihypertensive Drugs Sales and Growth Rate (2011-2016)
  4.1.2 France Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
  4.1.4 France Antihypertensive Drugs Sales Price Trend (2011-2016)
4.2 France Antihypertensive Drugs Sales and Market Share by Manufacturers
4.3 France Antihypertensive Drugs Sales and Market Share by Type
4.4 France Antihypertensive Drugs Sales and Market Share by Application

5 UK ANTIHYPERTENSIVE DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Antihypertensive Drugs Sales and Value (2011-2016)
  5.1.1 UK Antihypertensive Drugs Sales and Growth Rate (2011-2016)
  5.1.2 UK Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
  5.1.5 UK Antihypertensive Drugs Sales Price Trend (2011-2016)
5.2 UK Antihypertensive Drugs Sales and Market Share by Manufacturers
5.3 UK Antihypertensive Drugs Sales and Market Share by Type
5.4 UK Antihypertensive Drugs Sales and Market Share by Application

6 RUSSIA ANTIHYPERTENSIVE DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Antihypertensive Drugs Sales and Value (2011-2016)
  6.1.1 Russia Antihypertensive Drugs Sales and Growth Rate (2011-2016)
  6.1.2 Russia Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Antihypertensive Drugs Sales Price Trend (2011-2016)
6.2 Russia Antihypertensive Drugs Sales and Market Share by Manufacturers
6.3 Russia Antihypertensive Drugs Sales and Market Share by Type
6.4 Russia Antihypertensive Drugs Sales and Market Share by Application

7 ITALY ANTIHYPERTENSIVE DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Antihypertensive Drugs Sales and Value (2011-2016)
  7.1.1 Italy Antihypertensive Drugs Sales and Growth Rate (2011-2016)
  7.1.2 Italy Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Antihypertensive Drugs Sales Price Trend (2011-2016)
7.2 Italy Antihypertensive Drugs Sales and Market Share by Manufacturers
7.3 Italy Antihypertensive Drugs Sales and Market Share by Type
7.4 Italy Antihypertensive Drugs Sales and Market Share by Application

8 SPAIN ANTIHYPERTENSIVE DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Antihypertensive Drugs Sales and Value (2011-2016)
  8.1.1 Spain Antihypertensive Drugs Sales and Growth Rate (2011-2016)
  8.1.2 Spain Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Antihypertensive Drugs Sales Price Trend (2011-2016)
8.2 Spain Antihypertensive Drugs Sales and Market Share by Manufacturers
8.3 Spain Antihypertensive Drugs Sales and Market Share by Type
8.4 Spain Antihypertensive Drugs Sales and Market Share by Application

9 BENELUX ANTIHYPERTENSIVE DRUGS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Antihypertensive Drugs Sales and Value (2011-2016)
  9.1.1 Benelux Antihypertensive Drugs Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Antihypertensive Drugs Sales Price Trend (2011-2016)
9.2 Benelux Antihypertensive Drugs Sales and Market Share by Manufacturers
9.3 Benelux Antihypertensive Drugs Sales and Market Share by Type
9.4 Benelux Antihypertensive Drugs Sales and Market Share by Application

10 EUROPE ANTIHYPERTENSIVE DRUGS MANUFACTURERS ANALYSIS

10.1 Novartis AG
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Antihypertensive Drugs Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Novartis AG Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Pfizer
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Antihypertensive Drugs Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Pfizer Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Sanofi S.A
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Antihypertensive Drugs Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Sanofi S.A Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Johnson & Johnson
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Antihypertensive Drugs Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Johnson & Johnson Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Daiichi Sankyo
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Antihypertensive Drugs Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Daiichi Sankyo Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Merck & Co.
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Antihypertensive Drugs Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Merck & Co. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Ranbaxy Laboratories
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Antihypertensive Drugs Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Ranbaxy Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Lupin
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Antihypertensive Drugs Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Lupin Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 AstraZeneca
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Antihypertensive Drugs Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 AstraZeneca Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Dr. Reddy's Laboratories
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Antihypertensive Drugs Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Dr. Reddy's Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview

11 ANTIHYPERTENSIVE DRUGS MANUFACTURING COST ANALYSIS

11.1 Antihypertensive Drugs Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Antihypertensive Drugs

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Antihypertensive Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Antihypertensive Drugs Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE ANTIHYPERTENSIVE DRUGS MARKET FORECAST (2016-2021)

14.1 Germany Antihypertensive Drugs Sales Forecast (2016-2021)
14.2 France Antihypertensive Drugs Sales Forecast (2016-2021)
14.3 UK Antihypertensive Drugs Sales Forecast (2016-2021)
14.4 Russia Antihypertensive Drugs Sales Forecast (2016-2021)
14.5 Italy Antihypertensive Drugs Sales Forecast (2016-2021)
14.6 Spain Antihypertensive Drugs Sales Forecast (2016-2021)
14.7 Benelux Antihypertensive Drugs Sales Forecast (2016-2021)
14.8 Europe Antihypertensive Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Antihypertensive Drugs Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Antihypertensive Drugs
Table Classification of Antihypertensive Drugs
Figure Europe Sales Market Share of Antihypertensive Drugs by Type in 2015
Figure Angiotensin Converting Enzyme Inhibitors (ACE) Picture
Figure Diuretics Picture
Figure Beta Blockers Picture
Figure Calcium Channel Blockers Picture
Figure Vasodilators Picture
Figure Alpha blockers Picture
Figure Renin inhibitors Picture
Table Application of Antihypertensive Drugs
Figure Europe Sales Market Share of Antihypertensive Drugs by Application in 2015
Figure Diagnostic centers Examples
Figure Hospitals Examples
Figure Home health care Examples
Figure Germany Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
Figure France Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
2
Figure Russia Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Antihypertensive Drugs Sales and Growth Rate (2011-2021)
Figure Europe Antihypertensive Drugs Revenue and Growth Rate (2011-2021)
Table Europe Antihypertensive Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Antihypertensive Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antihypertensive Drugs Sales Share by Manufacturers
Figure 2016 Antihypertensive Drugs Sales Share by Manufacturers
Table Europe Antihypertensive Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Antihypertensive Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Antihypertensive Drugs Revenue Share by Manufacturers
Table 2016 Europe Antihypertensive Drugs Revenue Share by Manufacturers
Table Europe Antihypertensive Drugs Sales and Market Share by Type (2011-2016)
Table Europe Antihypertensive Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Antihypertensive Drugs by Type (2011-2016)
Figure Europe Antihypertensive Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Antihypertensive Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Antihypertensive Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Antihypertensive Drugs by Type (2011-2016)
Figure Europe Antihypertensive Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Antihypertensive Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Antihypertensive Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Antihypertensive Drugs by Countries (2011-2016)
Table Europe Antihypertensive Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Antihypertensive Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Antihypertensive Drugs by Countries (2011-2016)
Table Europe Antihypertensive Drugs Sales and Market Share by Application (2011-2016)
Table Europe Antihypertensive Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Antihypertensive Drugs by Application (2011-2016)
Figure Germany Antihypertensive Drugs Sales and Growth Rate (2011-2016)
Figure Germany Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Antihypertensive Drugs Sales Price Trend (2011-2016)
Table Germany Antihypertensive Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Antihypertensive Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Antihypertensive Drugs Sales by Type (2015 and 2016)
Table Germany Antihypertensive Drugs Market Share by Type (2015 and 2016)
Table Germany Antihypertensive Drugs Sales by Application (2015 and 2016)
Table Germany Antihypertensive Drugs Market Share by Application (2015 and 2016)
Figure France Antihypertensive Drugs Sales and Growth Rate (2011-2016)
Figure France Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
Figure France Antihypertensive Drugs Sales Price Trend (2011-2016)
Table France Antihypertensive Drugs Sales by Manufacturers (2015 and 2016)
Table France Antihypertensive Drugs Market Share by Manufacturers (2015 and 2016)
Table France Antihypertensive Drugs Sales by Type (2015 and 2016)
Table France Antihypertensive Drugs Market Share by Type (2015 and 2016)
Table France Antihypertensive Drugs Sales by Application (2015 and 2016)
Table France Antihypertensive Drugs Market Share by Application (2015 and 2016)
Figure UK Antihypertensive Drugs Sales and Growth Rate (2011-2016)
Figure UK Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
Figure UK Antihypertensive Drugs Sales Price Trend (2011-2016)
Table UK Antihypertensive Drugs Sales by Manufacturers (2015 and 2016)
Table UK Antihypertensive Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Antihypertensive Drugs Sales by Type (2015 and 2016)
Table UK Antihypertensive Drugs Market Share by Type (2015 and 2016)
Table UK Antihypertensive Drugs Sales by Application (2015 and 2016)
Table UK Antihypertensive Drugs Market Share by Application (2015 and 2016)
Figure Russia Antihypertensive Drugs Sales and Growth Rate (2011-2016)
Figure Russia Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Antihypertensive Drugs Sales Price Trend (2011-2016)
Table Russia Antihypertensive Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Antihypertensive Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Antihypertensive Drugs Sales by Type (2015 and 2016)
Table Russia Antihypertensive Drugs Market Share by Type (2015 and 2016)
Table Russia Antihypertensive Drugs Sales by Application (2015 and 2016)
Table Russia Antihypertensive Drugs Market Share by Application (2015 and 2016)
Figure Italy Antihypertensive Drugs Sales and Growth Rate (2011-2016)
Figure Italy Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Antihypertensive Drugs Sales Price Trend (2011-2016)
Table Italy Antihypertensive Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Antihypertensive Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Antihypertensive Drugs Sales by Type (2015 and 2016)
Table Italy Antihypertensive Drugs Market Share by Type (2015 and 2016)
Table Italy Antihypertensive Drugs Sales by Application (2015 and 2016)
Table Italy Antihypertensive Drugs Market Share by Application (2015 and 2016)
Figure Spain Antihypertensive Drugs Sales and Growth Rate (2011-2016)
Figure Spain Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Antihypertensive Drugs Sales Price Trend (2011-2016)
Table Spain Antihypertensive Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Antihypertensive Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Antihypertensive Drugs Sales by Type (2015 and 2016)
Table Spain Antihypertensive Drugs Market Share by Type (2015 and 2016)
Table Spain Antihypertensive Drugs Sales by Application (2015 and 2016)
Table Spain Antihypertensive Drugs Market Share by Application (2015 and 2016)
Figure Benelux Antihypertensive Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Antihypertensive Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Antihypertensive Drugs Sales Price Trend (2011-2016)
Table Benelux Antihypertensive Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Antihypertensive Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Antihypertensive Drugs Sales by Type (2015 and 2016)
Table Benelux Antihypertensive Drugs Market Share by Type (2015 and 2016)
Table Benelux Antihypertensive Drugs Sales by Application (2015 and 2016)
Table Benelux Antihypertensive Drugs Market Share by Application (2015 and 2016)
Table Antihypertensive Drugs Basic Information List
Table Novartis AG Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG Antihypertensive Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Antihypertensive Drugs Sales Market Share (2011-2016)
Table Sanofi S.A Basic Information List
Table Sanofi S.A Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A Antihypertensive Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Antihypertensive Drugs Sales Market Share (2011-2016)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo Antihypertensive Drugs Sales Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Antihypertensive Drugs Sales Market Share (2011-2016)
Table Ranbaxy Laboratories Basic Information List
Table Ranbaxy Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ranbaxy Laboratories Antihypertensive Drugs Sales Market Share (2011-2016)
Table Lupin Basic Information List
Table Lupin Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lupin Antihypertensive Drugs Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Antihypertensive Drugs Sales Market Share (2011-2016)
Table Dr. Reddy's Laboratories Basic Information List
Table Dr. Reddy's Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr. Reddy's Laboratories Antihypertensive Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antihypertensive Drugs
Figure Manufacturing Process Analysis of Antihypertensive Drugs
Figure Antihypertensive Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antihypertensive Drugs Major Manufacturers in 2015
Table Major Buyers of Antihypertensive Drugs
Table Distributors/Traders List
Figure Germany Antihypertensive Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Antihypertensive Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Antihypertensive Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Antihypertensive Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Antihypertensive Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Antihypertensive Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Antihypertensive Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Antihypertensive Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Antihypertensive Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Antihypertensive Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Antihypertensive Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Antihypertensive Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Antihypertensive Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Antihypertensive Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Antihypertensive Drugs Sales Forecast by Type (2016-2021)
Table Europe Antihypertensive Drugs Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories